Trials / Not Yet Recruiting
Not Yet RecruitingNCT06487026
Safety of ArcBlate MRgHIFU in Patients With Painful Bone Metastases: An Extension Study
An Extension Study to Evaluate the Safety of ArcBlate MRgHIFU in Patients With Painful Bone Metastases
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 25 (estimated)
- Sponsor
- EpiSonica · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
An Extension Study to Evaluate the Safety of ArcBlate MRgHIFU in Patients with Painful Bone Metastases
Detailed description
Pain palliation of bone metastasis through localized denervation by thermal ablation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | ArcBlate Focused Ultrasound Ablation System | MR-guided High Intensity Focused Ultrasound (MRgHIFU) |
Timeline
- Start date
- 2024-08-01
- Primary completion
- 2025-07-31
- Completion
- 2025-10-31
- First posted
- 2024-07-05
- Last updated
- 2024-07-05
Locations
4 sites across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT06487026. Inclusion in this directory is not an endorsement.